- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
This article has been retracted as it was found to contain a substantial amount of material from the manuscript titled “The volatile constituents of frankincense - a review” by Michaela Mertens, Andrea Buettnera, and Eva Kirchhoffa which was published in Flavour and Fragrance Journal, Volume 24, Issue 6, pages 279–300, November/December 2009, without proper citation.
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 140509, 12 pages
Chemistry and Biology of Essential Oils of Genus Boswellia
1Department of Biological Sciences and Chemistry, College of Arts and Sciences, University of Nizwa, Birkat Al-Mouz, 616 Nizwa, Oman
2Department of Chemistry, University of Paderborn, Warburger Straße 100, 33098 Paderborn, Germany
Received 2 December 2012; Accepted 28 January 2013
Academic Editor: Ruixin Zhang
Copyright © 2013 Hidayat Hussain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. Vollesen, “Burseraceae,” in Flora of Ethiopia, I. Hedberg and S. Edwards, Eds., vol. 3, pp. 442–447, National Herbarium, Addis Ababa University, Addis Ababa, Ethiopia, 1989.
- A. Dekebo, Phytochemical studies on the resin of some Commiphora and Boswellia spp. [Ph.D. thesis], Addis Ababa University, Addis Ababa, Ethiopia, 2001.
- G. H. Kindeya, Ecology and management of Boswellia papyrifera (Del.) Hochst. Dry forest in Tigray, Northern Ethiopia [Ph.D. thesis], Culvillier, Gottingen, Germany, 2003.
- A. O. Tucker, “Frankincense and myrrh,” Economic Botany, vol. 40, no. 4, pp. 425–433, 1986.
- A. Moussaieff and R. Mechoulam, “Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials,” Journal of Pharmacy and Pharmacology, vol. 61, no. 10, pp. 1281–1293, 2009.
- H. P. Ammon, “Boswellic acids in chronic inflamatory diseases,” Planta Medica, vol. 72, no. 12, pp. 1100–1116, 2006.
- D. Poeckel and O. Werz, “Boswellic acids: biological actions and molecular targets,” Current Medicinal Chemistry, vol. 13, no. 28, pp. 3359–3369, 2006.
- B. A. Shah, G. N. Qazi, and S. C. Taneja, “Boswellic acids: a group of medicinally important compounds,” Natural Product Reports, vol. 26, no. 1, pp. 72–89, 2009.
- Shanghai Scientific and Technologic Press, Dictionary of Chinese Traditional Medicines, Shogakkan, Tokyo, Japan, 1985.
- H. Safayhi and H. P. T. Ammon, “Pharmakologische Aspecte von Weihrauch und Boswelliasauren,” Pharmazeutisch Zeitung, vol. 142, pp. 3277–3280, 1997.
- H. Safayhi, S. E. Boden, S. Schweizer, and H. P. T. Ammon, “Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL,” Planta Medica, vol. 66, no. 2, pp. 110–113, 2000.
- A. Y. Fan, L. Lao, R. X. Zhang et al., “Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats,” Journal of Ethnopharmacology, vol. 101, no. 1–3, pp. 104–109, 2005.
- B. Büchele, W. Zugmaier, A. Estrada et al., “Characterization of 3α-Acetyl-11-keto-α-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo,” Planta Medica, vol. 72, no. 14, pp. 1285–1289, 2006.
- N. Banno, T. Akihisa, K. Yasukawa et al., “Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri,” Journal of Ethnopharmacology, vol. 107, no. 2, pp. 249–253, 2006.
- T. Akihisa, K. Tabata, N. Banno et al., “Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri,” Biological and Pharmaceutical Bulletin, vol. 29, no. 9, pp. 1976–1979, 2006.
- S. Basar, Phytochemical investigations on Boswelia species [Ph.D. thesis], University of Hamburg, Hamburg, Germany, 2005.
- H. Obermann, “Die chemischen und geruchlichen Unterschiede von Weihrauchharzen,” Dragoco Report, vol. 24, pp. 260–265, 1977.
- S. Hamm, J. Bleton, J. Connan, and A. Tchapla, “A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples,” Phytochemistry, vol. 66, no. 12, pp. 1499–1514, 2005.
- S. Basar, A. Koch, and W. A. König, “A verticillane-type diterpene from Boswellia carterii essential oil,” Flavour and Fragrance Journal, vol. 16, no. 5, pp. 315–318, 2001.
- B. R. Mikhaeil, G. T. Maatooq, F. A. Badria, and M. M. A. Amer, “Chemistry and immunomodulatory activity of frankincense oil,” Zeitschrift fur Naturforschung C, vol. 58, no. 3-4, pp. 230–238, 2003.
- M. Mertens, A. Buettner, and E. Kirchhoff, “The volatile constituents of frankincense—a review,” Flavour and Fragrance Journal, vol. 24, no. 6, pp. 279–300, 2009.
- B. Singh, R. Kumar, S. Bhandari, S. Pathania, and B. Lai, “Volatile constituents of natural Boswellia serrata oleo-gum-resin and commercial samples,” Flavour and Fragrance Journal, vol. 22, no. 2, pp. 145–147, 2007.
- J. Verghese, M. T. Joy, J. A. Retamar, G. G. Malinskas, C. A. N. Catalan, and E. G. Gros, “A fresh look at the constituents of Indian Olibanum oil,” Flavour Fragrance Journal, vol. 2, no. 3, pp. 99–102, 1987.
- L. Camarda, T. Dayton, V. Di Stefano, R. Pitonzo, and D. Schillaci, “Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae),” Annali di Chimica, vol. 97, no. 9, pp. 837–844, 2007.
- A. Al-Harrasi and S. Al-Saidi, “Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani luban),” Molecules, vol. 13, no. 9, pp. 2181–2189, 2008.
- B. Marongiu, A. Piras, S. Porcedda, and E. Tuveri, “Extraction of Santalum album and Boswellia carterii Birdw. volatile oil by supercritical carbon dioxide: influence of some process parameters,” Flavour and Fragrance Journal, vol. 21, no. 4, pp. 718–724, 2006.
- K. H. C. Başer, B. Demirci, A. Dekebo, and E. Dagne, “Essential oils of some Boswellia spp., myrrh and opopanax,” Flavour and Fragrance Journal, vol. 18, no. 2, pp. 153–156, 2003.
- M. Pailer, O. Scheidl, H. Gutwillinger, E. Klein, and H. Obermann, “Über die Zusammensetzung des Pyrolysates von Weihrauch “Aden”, dem Gummiharz von Boswellia carteri Birdw., 1. Mitt,” Monatshefte für Chemie, vol. 112, no. 3, pp. 341–358, 1981.
- N. A. Awadh Ali, M. Wurster, N. Arnold, U. Lindequist, and L. Wessjohann, “Chemical composition and biological activities of essential oils from the Oleogum resins of three endemic Soqotraen Boswellia species,” Records of Natural Products, vol. 2, no. 1, pp. 6–12, 2009.
- G. Strappaghetti, S. Corsano, A. Craveiro, and G. Proietti, “Constituents of essential oil of Boswellia frereana,” Phytochemistry, vol. 21, no. 8, pp. 2114–2115, 1982.
- R. A. A. Mothana, S. S. Hasson, W. Schultze, A. Mowitz, and U. Lindequist, “Phytochemical composition and in vitro antimicrobial and antioxidant activities of essential oils of three endemic Soqotraen Boswellia species,” Food Chemistry, vol. 126, no. 3, pp. 1149–1154, 2011.
- S. F. van Vuuren, G. P. P. Kamatou, and A. M. Viljoen, “Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples,” South African Journal of Botany, vol. 76, no. 4, pp. 686–691, 2010.
- A. Dekebo, M. Zewdu, and E. Dagne, “Volatile oils of frankincense from Boswellia papyrifera,” Bulletin of the Chemical Society of Ethiopia, vol. 13, no. 1, pp. 93–96, 1999.
- S. Al-Saidi, K. B. Rameshkumar, A. Hisham, N. Sivakumar, and S. Al-Kindy, “Composition and antibacterial activity of the essential oils of four commercial grades of Omani Luban, the oleo-gum resin of Boswellia sacra,” Chemistry and Biodiversity, vol. 9, no. 3, pp. 615–624, 2012.
- C. L. Woolley, M. M. Suhail, B. L. Smith et al., “Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry,” Journal Chromatography A, vol. 1261, pp. 158–163, 2012.
- A. Dekebo, E. Dagne, O. R. Gautun, and A. J. Aasen, “Triterpenes from the resin of Boswellia neglecta,” Bulletin of the Chemical Society of Ethiopia, vol. 16, no. 1, pp. 87–90, 2002.
- S. M. Abdel Wahab, E. A. Aboutabl, S. M. El-Zalabani, H. A. Fouad, H. L. de Pooter, and B. El-Fallaha, “The essential oil of olibanum,” Planta Medica, vol. 53, no. 4, pp. 382–384, 1987.
- M. T. Baratta, H. J. D. Dorman, S. G. Deans, D. M. Biondi, and G. Ruberto, “Chemical composition, antimicrobial and antioxidative activity of laurel, sage, rosemary, oregano and coriander essential oils,” Journal of Essential Oil Research, vol. 10, no. 6, pp. 618–627, 1998.
- G. Ruberto and M. T. Baratta, “Antioxidant activity of selected essential oil components in two lipid model systems,” Food Chemistry, vol. 69, no. 2, pp. 167–174, 2000.
- N. Mimica-Dukic, B. Bozin, M. Sokovic, and N. Simin, “Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil,” Journal of Agricultural and Food Chemistry, vol. 52, no. 9, pp. 2485–2489, 2004.
- N. Mimica-Dukić, B. Božin, M. Soković, B. Mihajlović, and M. Matavulj, “Antimicrobial and antioxidant activities of three Mentha species essential oils,” Planta Medica, vol. 69, no. 5, pp. 413–419, 2003.
- M. Miyazawa and C. Yamafuji, “Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids,” Journal of Agricultural and Food Chemistry, vol. 53, no. 5, pp. 1765–1768, 2005.
- Y. Shao, C. T. Ho, C. K. Chin, V. Badmaev, W. Ma, and M. T. Huang, “Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture,” Planta Medica, vol. 64, no. 4, pp. 328–331, 1998.
- C. F. Carson and T. V. Riley, “Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia,” Journal of Applied Bacteriology, vol. 78, no. 3, pp. 264–269, 1995.
- S. Pattnaik, V. R. Subramanyam, M. Bapaji, and C. R. Kole, “Antibacterial and antifungal activity of aromatic constituents of essential oils,” Microbios, vol. 89, no. 358, pp. 39–46, 1997.
- K. E. Wesenberg-Ward, B. J. Tyler, and J. T. Sears, “Adhesion and biofilm formation of Candida albicans on native and pluronic-treated polystyrene,” Biofilms, vol. 2, no. 1, pp. 63–71, 2005.
- D. Schillaci, V. Arizza, T. Dayton, L. Camarda, and V. Di Stefano, “In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils,” Letters in Applied Microbiology, vol. 47, no. 5, pp. 433–438, 2008.
- K. K. Aggarwal, S. P. S. Khanujia, A. Ahmed, T. R. S. Kumar, V. Gupta, and S. Kumar, “Antimicrobial activity profiles of the two enantiomers of limonene and carvone isolated from the oils of Mentha spicata and Anethum sowa,” Flavour and Fragrance Journal, vol. 17, no. 1, pp. 59–63, 2002.
- F. M. Abdoul-latif, L. C. Obame, I. H. N. Bassolé, and M. H. Dicko, “Antimicrobial activities of essential oil and methanol extract of Boswellia sacra Flueck. and Boswellia papyrifera (Del.) Hochst from Djibouti,” International Journal of Management, Modern Sciences and Technologies, vol. 1, pp. 1–10, 2012.
- M. B. Frank, Q. Yang, J. Osban et al., “Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity,” BMC Complementary and Alternative Medicine, vol. 9, article 6, 2009.
- M. M. Suhail, W. Wu, A. Cao et al., “Boswellia sacra essential oil induces tumor cellspecific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells,” Complementary and Alternative Medicine, vol. 11, pp. 129–142, 2011.
- X. Feng, Z. Wu, Y. Wu et al., “Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells,” Molecular and Cellular Biology, vol. 31, no. 16, pp. 3457–3471, 2011.
- J. M. Gozgit, B. T. Pentecost, S. A. Marconi, C. N. Otis, C. Wu, and K. F. Arcaro, “Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer,” Molecular Cancer Research, vol. 4, no. 12, pp. 905–913, 2006.
- C. Y. Sasaki and A. Passaniti, “Identification of anti-invasive but noncytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitate viable cells in matrigel,” BioTechniques, vol. 24, no. 6, pp. 1038–1043, 1998.
- Z. Liang, T. Wu, H. Lou et al., “Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4,” Cancer Research, vol. 64, no. 12, pp. 4302–4308, 2004.
- R. M. Sutherland, H. A. Eddy, B. Bareham, K. Reich, and D. Vanantwerp, “Resistance to adriamycin in multicellulr spheroids,” International Journal of Radiation Oncolology Biolohy Physics, vol. 5, no. 8, pp. 1225–1230, 1979.
- G. W. West, R. Weichselbaum, and J. B. Little, “Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjurant chemotherapy,” Cancer Research, vol. 40, no. 10, pp. 3665–3668, 1980.
- H. J. Lin, F. C. Hsieh, H. Song, and J. Lin, “Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer,” British Journal of Cancer, vol. 93, no. 12, pp. 1372–1381, 2005.
- J. Cicenas, P. Urban, V. Vuaroqueaux et al., “Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2,” Breast Cancer Research, vol. 7, no. 4, pp. R394–R401, 2005.
- G. Pérez-Tenorio, O. Stål, L. G. Arnesson et al., “Activation of Akt/PKB in breast cancer predicts a worse outcome among endocrine treated patients,” British Journal of Cancer, vol. 86, no. 4, pp. 540–545, 2002.
- S. Svensson, K. Jirström, L. Rydén et al., “ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis,” Oncogene, vol. 24, no. 27, pp. 4370–4379, 2005.
- J. M. Gee, J. F. Robertson, I. O. Ellis, and R. I. Nicholson, “Phosphrylation of ERk1/2 mitogen-activated protein kinase is associated poor response to anti-hormonal therapy and decreased patient survival in colinical breast cancer,” International Journal Cancer, vol. 95, no. 4, pp. 247–254, 2001.
- T. Frogne, J. S. Jepsen, S. S. Larsen, C. K. Fog, B. L. Brockdorff, and A. E. Lykkesfeldt, “Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth,” Endocrine-Related Cancer, vol. 12, no. 3, pp. 599–614, 2005.
- Y. Cui, I. Parra, M. Zhang et al., “Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance,” Cancer Research, vol. 66, no. 11, pp. 5950–5959, 2006.
- M. Beeram, Q. T. N. Tan, R. R. Tekmal, D. Russell, A. Middleton, and L. A. deGraffenried, “Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling,” Annals of Oncology, vol. 18, no. 8, pp. 1323–1328, 2007.
- L. A. deGraffenried, W. E. Friedrichs, D. H. Russell et al., “Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity,” Clinical Cancer Research, vol. 10, no. 23, pp. 8059–8067, 2004.
- D. C. Lev, L. S. Kim, V. Melnikova, M. Ruiz, H. N. Ananthaswamy, and J. E. Price, “Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells,” British Journal of Cancer, vol. 91, no. 4, pp. 795–802, 2004.
- J. J. Liu and R. D. Duan, “LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells,” Anticancer Research, vol. 29, no. 8, pp. 2987–2991, 2009.